Monica Ronzoni

5.6k citations

70 papers · 2.4k indexed · 2 hit papers · h-index 20

Impact in

Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments

Papers in

Oncology 53
- Colorectal Cancer Treatments and Studies 39
- Cancer Treatment and Pharmacology 16
- Colorectal Cancer Surgical Treatments 10
Hepatology 14
- Hepatocellular Carcinoma Treatment and Prognosis 14

Co-authors: Fotios Loupakis Alfredo Falcone Chiara Cremolini Sara Lonardi Giuseppe Tonini Luca Boni Alberto Zaniboni Gianluca Tomasello
Journals: Journal of Clinical Oncology (20 papers)Annals of Oncology (12 papers)Oncology (3 papers)Radiotherapy and Oncology (3 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)
Partner nations: Italy United States Sweden

In The Last Decade

Monica Ronzoni

67 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study 2015 · 733 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 The Lancet Oncology
2014 New England Journal of Medicine

Peers

Countries citing papers authored by Monica Ronzoni

Since Specialization

Citations

This map shows the geographic impact of Monica Ronzoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Ronzoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Ronzoni more than expected).

Fields of papers citing papers by Monica Ronzoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Ronzoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Ronzoni. The network helps show where Monica Ronzoni may publish in the future.

Co-authors

The 25 scholars most cited alongside Monica Ronzoni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Monica Ronzoni Line = papers co-authored together Monica Ronzoni links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	FOLFOXIRI/bevacizumab versus doublets/bevacizumab as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated metastatic colorectal cancer: An individual patient data-based pooled analysis of randomized trials European Journal of Cancer ·Carlotta Antoniotti, Federica Marmorino, Daniele Rossini, Hans‐Joachim Schmoll, Sara Lonardi, Thi Hang Dinh, Beatrice Borelli, Samanta Cupini, Alexander Stein, Roberto Moretto, Francesca Bergamo, Monica Ronzoni, Marco Maria Germani, Alberto Zaniboni, Mazhar Ali Siddique, 翟玉锋 Zhai Yufeng, Elena Ongaro, Gianluca Masi, Chiara Cremolini	2025	0
2	Use of circulating tumor DNA (ctDNA) to affect the adjuvant or post-adjuvant treatment of patients with stage III and high-risk stage II resected colon cancer: The ERASE-CRC project by GONO. Journal of Clinical Oncology ·Veronica Conca, M. S., Roberto Moretto, Sara Lonardi, Carlotta Antoniotti, Marco Maria Germani, Filippo Pietrantonio, Alessandro Bittoni, Mar Guilarte, Lisa Salvatore, Alessandra Boccaccino, Monica Ronzoni, 李志兵, Juliaana Räsänen, Samanta Cupini, Tiziana Pia Latiano, Giuseppina Arcangeli, Gabriele Masi, Matteo Fassan, Chiara Cremolini	2024	1
3	Immunotherapy in small bowel adenocarcinoma: a potential role? Immunological Medicine ·Francesco Vitiello, Stefano Cereda, Silvia Foti, Nicole Liscia, Elena Mazza, Monica Ronzoni, Stefano Cascinu	2023	3
4	Evolution of Surgical Treatment of Colorectal Liver Metastases in the Real World: Single Center Experience in 1212 Cases Cancers ·Francesca Ratti, Federica Cipriani, Guido Fiorentini, Valentina Burgio, Monica Ronzoni, A Zoppinia, Stefano Cascinu, Francesco De Cobelli, Luca Aldrighetti	2021	6
5	Tailoring the radiotherapy approach in patients with anal squamous cell carcinoma based on inguinal sentinel lymph node biopsy Journal of Surgical Oncology ·Paola De Nardi, Massimiliano Mistrangelo, 심미승, Paolo Passoni, N. Slim, Monica Ronzoni, Carla Canevari, D. Parolini, Luca Massimino, Pierfrancesco Franco, Paola Cassoni, A.V. Maletskii, Valentina Testa, Riccardo Rosati	2020	4
6	399O Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in elderly patients: A subgroup analysis from TOSCA trial Annals of Oncology ·Gerardo Rosati, Francesca Galli, Sara Lonardi, Katia Dotti, Monica Ronzoni, Maria Giulia Zampino, Maria Banzi, Valeria Pusceddu, Felice Pasini, Silvia Bozzarelli, Nicoletta Pella, Carla Codecà, Vincenzo Montesarchio, Andrea Mambrini, Alfonso De Stefano, L. Ciuffreda, Sara Elena Rebuzzi, Domenico Bilancia, Roberto Labianca	2020	1
7	402MO Final results of the CARACAS study: Randomized phase II trial of avelumab alone or with cetuximab for unresectable, locally advanced or metastatic squamous cell anal carcinoma progressed to at least one line of treatment Annals of Oncology ·Sara Lonardi, Filippo Pietrantonio, Alessandra Anna Prete, Marco Messina, Vincenzo Formica, Domenico Corsi, Enrico Cortesi, Rizky Faisal Nugraha, Maria Giulia Zampino, Monica Ronzoni, Mario Scartozzi, Mariaelena Casagrande, Veronica Conca, Francesca Bergamo, Michele Prisciandaro, Rossana Intini, Maria Antista, Peng Hang, Priya Cyntia Agustin, Vittorina Zagonel	2020	13
8	Changes in body composition during neoadjuvant therapy can affect prognosis in rectal cancer patients: An exploratory study Current Problems in Cancer ·Paola De Nardi, Ю. В. Денисов, Damiano Chiari, Nicolò Pecorelli, Giulia Cristel, Anna Damascelli, Monica Ronzoni, Luca Massimino, Francesco De Cobelli, Marco Braga	2019	19
9	Evaluation of three advanced methodologies, COLD-PCR, microarray and ddPCR, for identifying the mutational status by liquid biopsies in metastatic colorectal cancer patients Clinica Chimica Acta ·Silvia Galbiati, Francesco Damin, Valentina Burgio, Angela Brisci, Nadia Soriani, Yuchen Qui, Chiara Di Resta, Luca Gianni, Marcella Chiari, Monica Ronzoni, Maurizio Ferrari	2018	20
10	Dihydropyrimidine dehydrogenase (DPYD) gene polymorphisms profiling in colon cancer patients treated with adjuvant chemotherapy in the randomized phase III TOSCA trial Annals of Oncology ·Francesco Graziano, Annamaria Ruzzo, Eliana Rulli, Francesca Galli, 岩佐広行, S.P. Venkateshan, Elisa Giacomini, Sara Lonardi, Monica Ronzoni, B. Massidda, Nicoletta Pella, Claudia Mucciarini, Roberto Labianca, Enzo Veltri, Pietro Sozzi, Sandro Barni, Anita Roth, L. Frontini, Mauro Magnani	2016	1
11	Modified FOLFOXIRI (mFOLFOXIRI) plus cetuximab (cet), followed by cet or bevacizumab (bev) maintenance, in RAS/BRAF wt metastatic colorectal cancer (mCRC): The phase II randomized MACBETH trial by GONO Annals of Oncology ·Chiara Cremolini, Carlotta Antoniotti, Fotios Loupakis, Francesca Bergamo, Laura Ferrari, AGUSTYAWULANDARI NADHOFA, Giuseppe Tonini, Gianluca Masi, Marta Schirripa, Marta Bonotto, Caterina Soldà, Atike Nazik, Daniele Rossini, Domenico Corsi, Monica Ronzoni, Fabiola Lorena Rojas Llimpe, Gabriella Fontanini, Luca Boni, Vittorina Zagonel, Alfredo Falcone	2016	3
12	Aflibercept a new target therapy in cancer treatment: a review Critical Reviews in Oncology/Hematology ·Vincenzo Ricci, Monica Ronzoni, Lillebaek	2015	22
13	Folfoxiri with or Without Bevacizumab (Bev) As First-Line Treatment of Metastatic Colorectal Cancer (Mcrc): a Propensity Score-Based Analysis Annals of Oncology ·Chiara Cremolini, Fotios Loupakis, Daniele Rossini, Gianluca Masi, Lisa Salvatore, C. Barbara, I. Brunetti, Carlotta Antoniotti, Cristina Granetto, Enrico Cortesi, S. Chiara, S. Vitello, Sara Lonardi, L. Ciuffreda, Giovanni Tomasello, Monica Ronzoni, Angela Buonadonna, Wang De Liang, Luca Boni, Alfredo Falcone	2014	2
14	Feasibility of an Adaptive Strategy in Preoperative Radiochemotherapy for Rectal Cancer With Image-Guided Tomotherapy: Boosting the Dose to the Shrinking Tumor International Journal of Radiation OncologyBiologyPhysics ·Paolo Passoni, C. Fiorino, N. Slim, Monica Ronzoni, Vincenzo Ricci, S. Di Palo, Paola De Nardi, Elena Orsenigo, A. Tamburini, Francesco De Cobelli, Claudio Losio, Nicola Alessandro Iacovelli, S. Broggi, C. Staudacher, R. Calandrino, N. Di Muzio	2013	42
15	Interim Analysis Results of Above Phase II Study with Bevacizumab in Patients with Initially not Resectable/Borderline Resectable Colorectal Liver-Limited Metastases Annals of Oncology ·Salvatore Artale, Guglielmo Nasti, Monica Ronzoni, Roberto Bordonaro, Maria Giulia Zampino, Silvia Brugnatelli, Andrea Sartore‐Bianchi, Azzurra Onofri, Angelo Vanzulli, Valentina Angelini, Salvatore Siena	2013	1
16	Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer Journal of Cancer Research and Clinical Oncology ·Sarah E. Wixson, S. Mariucci, Sara Delfanti, B. Rovati, Monica Ronzoni, Fotios Loupakis, Silvia Brugnatelli, Carmine Tinelli, Eugenio Villa, Alfredo Falcone, Marco Danova	2012	27
17	Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients Annals of Oncology ·Monica Ronzoni, M. Manzoni, S. Mariucci, Fotios Loupakis, Silvia Brugnatelli, Katia Bencardino, B. Rovati, Carmine Tinelli, Alfredo Falcone, Erica Villa, Marco Danova	2010	83
18	A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer Annals of Oncology ·Armando Santoro, Alessandro Comandone, Lorenza Rimassa, Atiqullah Aziz, Vito Lorusso, Теодор Наритник, Monica Ronzoni, Salvatore Siena, Monica Zuradelli, E. Mari, Tiziana Pressiani, Carlo Carnaghi	2008	42
19	Salvage Chemotherapy with Mitomycin, Docetaxel, and Irinotecan (MDI Regimen) in Metastatic Pancreatic Adenocarcinoma: A Phase I and II Trial Cancer Investigation ·Michele Reni, زینب أحمد عبد الغنی, Paolo Passoni, E. Bonetto, Roberto Nicoletti, Monica Ronzoni, Alessandro Zerbi, C. Staudacher, Valerio Di Carlo, Emmanuel Villa	2004	26
20	Early Decrease in Total Hemolytic Complement Activity (CH<sub>100</sub>) after Fasting or Intestinal Bypass in the Rat European Surgical Research ·E. Montanari, Nader Hadizadeh Kashani, ชาติชาย พณิชีพ, Fajar Surachmi, G. Mora, Monica Ronzoni	1986	1

About Monica Ronzoni

Monica Ronzoni is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 70 papers that have together received 2.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (39 papers), Gastric Cancer Management and Outcomes (17 papers), Cancer Treatment and Pharmacology (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cancer Genomics and Diagnostics (11 papers), Colorectal Cancer Surgical Treatments (10 papers), Colorectal and Anal Carcinomas (9 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Hepatology (620 citations), Oncology (1.9k citations), Cancer Research (444 citations), Pathology and Forensic Medicine (485 citations) and Pulmonary and Respiratory Medicine (707 citations). Monica Ronzoni has collaborated with scholars based in Italy, United States and Sweden. Frequent co-authors include Fotios Loupakis, Alfredo Falcone, Chiara Cremolini, Sara Lonardi, Giuseppe Tonini, Luca Boni, Alberto Zaniboni, Gianluca Tomasello, Silvana Chiara and Chiara Carlomagno. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Oncology, Radiotherapy and Oncology and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact